DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Baghdasaryan A, Claudel T, Gumhold J. , et al.
Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO−3 output.

Hepatology 2011;
54 (04) 1303-1312

Baghdasaryan A, Claudel T, Gumhold J. , et al.
Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO−3 output.

Hepatology 2011;
54 (04) 1303-1312

Download Bibliographical Data

Search in:
Access: